On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

University of Arkansas Medical Center

InstitutionResearch output, impact & collaborations

University of Arkansas Medical Center is a institution indexed in ScholarIQ from OpenAlex.

What is known about University of Arkansas Medical Center?

ScholarIQrecord summary

University of Arkansas Medical Center is a research organisation in Little Rock, US. OpenAlex records 4,274 works and 251,120 citations for it. 889 researchers list it as their most recent affiliation.

How many works does University of Arkansas Medical Center have?

ScholarIQindexed works

University of Arkansas Medical Center has 4,274 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does University of Arkansas Medical Center have?

ScholarIQcitation count

University of Arkansas Medical Center has 251,120 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at University of Arkansas Medical Center?

ScholarIQresearcher count

University of Arkansas Medical Center has 889 researchers in the ScholarIQ index.

What is the average h-index at University of Arkansas Medical Center?

ScholarIQavg h-index

University of Arkansas Medical Center has an average h-index of 70 in OpenAlex.

What is the ROR of University of Arkansas Medical Center?

ScholarIQror

The ROR for University of Arkansas Medical Center is on the source record.

What is the OpenAlex record for University of Arkansas Medical Center?

ScholarIQopenalex

The OpenAlex for University of Arkansas Medical Center is on the source record.

What is the Wikidata of University of Arkansas Medical Center?

ScholarIQwikidata

The Wikidata for University of Arkansas Medical Center is on the source record.

Who are the most-cited researchers behind University of Arkansas Medical Center?

ScholarIQtop researchers by citations
1
Michael J. Birrer · Ovarian cancer diagnosis and treatment
1,068 works90,601 citations
2
Jawahar L. Mehta · Atherosclerosis and Cardiovascular Diseases
654 works39,284 citations
3
Michael S. Robeson · Gut microbiota and health
98 works32,889 citations
4
Intawat Nookaew · Biomarkers in Disease Mechanisms
347 works18,465 citations
5
Charles A. O’Brien · Bone health and treatments
187 works17,774 citations

What are the most-cited papers on University of Arkansas Medical Center?

ScholarIQmost cited works
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Robert A. Burger, Mark F. Brady, Michael A. Bookman, Gini F. Fleming, Bradley J. Monk, Helen Huang, Robert S. Mannel, Howard D. Homesley, Jeffrey M. Fowler, Benjamin E. Greer, Matthew Boente, Michael J. Birrer, Sharon X. Liang
New England Journal of Medicine. 20112,398 CitationsOPEN ACCESS
Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
Marcel Verheij, Ron Bose, Xin Lin, Bei Yao, W. David Jarvis, Steven Grant, Michael J. Birrer, Éva Szabó, Leonard I. Zon, John Kyriakis, Adriana Haimovitz‐Friedman, Zvi Fuks, Richard Kolesnick
Nature. 19961,796 Citations
Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use — United States, 2006–2015
Anuj Shah, Corey J. Hayes, Bradley C. Martin
MMWR Morbidity and Mortality Weekly Report. 2017968 CitationsOPEN ACCESS
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients
Thomas Condamine, George A. Dominguez, Je‐In Youn, Andrew V. Kossenkov, Sridevi Mony, Kevin Alicea-Torres, Evgenii N. Tcyganov, Ayumi Hashimoto, Yulia Nefedova, Cindy Lin, Simona Partlová, Alfred L. Garfall, Dan T. Vogl, Xiaowei Xu, Stella C. Knight, George Malietzis, Gui Han Lee, Evgeniy Eruslanov, Steven Μ. Albelda, Xianwei Wang, Jawahar L. Mehta, Meenakshi Bewtra, Anil K. Rustgi, Neil Hockstein, Robert Witt, Gregory A. Masters, Brian Nam, Denis A. Smirnov, Manuel A. Sepúlveda, Dmitry I. Gabrilovich
Science Immunology. 2016810 Citations
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
Krishnansu S. Tewari, Michael W. Sill, Richard T. Penson, Helen Huang, Lois M. Ramondetta, Lisa M. Landrum, Ana Oaknin, Thomas Reid, Mario M. Leitão, Helen E. Michael, Philip J. DiSaia, Larry J. Copeland, William T. Creasman, Frederick B. Stehman, Mark F. Brady, Robert A. Burger, J.T. Thigpen, Michael J. Birrer, Steven Waggoner, David H. Moore, Katherine Y. Look, Wui-Jin Koh, Bradley J. Monk
The Lancet. 2017686 CitationsOPEN ACCESS

How much of the research on University of Arkansas Medical Center is open access?

ScholarIQopen access share
50%OPEN ACCESS
Gold
0%
Green
17%
Hybrid
8%
Bronze
25%
Closed
50%

Related on ScholarIQ

470M+ articles · 14-day free trial